Moreover, even when ER expression is still retained, molecular rewiring of the signaling pathways through the engagement of alternative RTKs such as EGFR [26], HER2 [27], and FGFR [28] can lead to the reactivation of ER-regulated transcription programs and tumor cell growth. Here, EGFR is linked to neoplasm.